Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Geoffroy Andrieux | |||||||
GSE241162 |
Oncogenic Calreticulin Induces Immune Escape by Stimulating TGF-β Expression and Regulatory T Cell Expansion in the Bone Marrow Microenvironment - microarray
|
8 | Geoffroy Andrieux | May 30, 2024 | ||||
GSE241364 |
Oncogenic Calreticulin Induces Immune Escape by Stimulating TGF-β Expression and Regulatory T Cell Expansion in the Bone Marrow Microenvironment - scRNAseq
|
4 | Geoffroy Andrieux | May 30, 2024 | ||||
GSE241365 |
Oncogenic Calreticulin Induces Immune Escape by Stimulating TGF-β Expression and Regulatory T Cell Expansion in the Bone Marrow Microenvironment
|
12 | Geoffroy Andrieux | May 28, 2024 | ||||
GSE241778 |
On- and off-target effects of paired CRISPR-Cas nickase in primary human cells - Illumina
|
18 | Geoffroy Andrieux | Mar 15, 2024 | ||||
GSE241779 |
On- and off-target effects of paired CRISPR-Cas nickase in primary human cells - long-read
|
6 | Geoffroy Andrieux | Mar 15, 2024 | ||||
GSE241780 |
On- and off-target effects of paired CRISPR-Cas nickase in primary human cells
|
62 | Geoffroy Andrieux | Mar 15, 2024 | ||||
GSE242954 |
On- and off-target effects of paired CRISPR-Cas nickase in primary human cells - Amplicon sequencing
|
18 | Geoffroy Andrieux | Mar 15, 2024 | ||||
GSE254922 |
On- and off-target effects of paired CRISPR-Cas nickase in primary human cells - long read
|
14 | Geoffroy Andrieux | Mar 15, 2024 | ||||
GSE255081 |
On- and off-target effects of paired CRISPR-Cas nickase in primary human cells [Amplicon]
|
6 | Geoffroy Andrieux | Mar 15, 2024 | ||||
GSE145513 |
RNA expression of human naive B cells either unstimulated or activated with CD40L in presence or absence of transient Fas engagement
|
12 | Geoffroy Andrieux | Mar 07, 2024 | ||||
GSE226432 |
The effect of LCN2 treatment on anti-inflammatory bone marrow derived macrophages
|
9 | Geoffroy Andrieux | Jan 24, 2024 | ||||
GSE193696 |
Microglia activation during CAR T cell induced neurotoxicity is dependent on TGF-β-activated kinase-1
|
8 | Geoffroy Andrieux | Jan 22, 2024 | ||||
GSE243587 |
Cell-based models of ‘Cytokine Release Syndrome’ endorse CD40L and GM-CSF knockout in CAR T cells as mitigation strategy
|
12 | Geoffroy Andrieux | Dec 06, 2023 | ||||
GSE229043 |
Effect of ROCK Inhibitor on myeloid cells during GvHD
|
7 | Geoffroy Andrieux | Dec 04, 2023 | ||||
GSE242432 |
BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia
|
6 | Geoffroy Andrieux | Nov 14, 2023 | ||||
GSE245791 |
Efficient and Safe Therapeutic Use of Paired Cas9-Nickases for Primary Hyperoxaluria Type 1
|
14 | Geoffroy Andrieux | Nov 10, 2023 | ||||
GSE243226 |
Gene-expression study of primary human anti-CD19 CAR T cells in vitro with or with out stimulation with target cells
|
36 | Geoffroy Andrieux | Nov 01, 2023 | ||||
GSE138439 |
Loss of L-cells due to acute graft-versus-host disease leads to Paneth cell defects which can be compensated by glucagon like peptide-2
|
8 | Geoffroy Andrieux | Oct 29, 2023 | ||||
GSE189822 |
Xenograft mouse model to investigate tropism to the CNS and retina in primary central nervous system lymphoma (first batch)
|
14 | Geoffroy Andrieux | Oct 11, 2023 | ||||
GSE218284 |
Xenograft mouse model to investigate tropism to the CNS and retina in primary central nervous system lymphoma (second batch)
|
4 | Geoffroy Andrieux | Oct 11, 2023 |